NRXS
USDNeuraxis Inc. Common Stock
$2.540-0.120 (-4.511%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$2.660
고가
$2.630
저가
$2.520
거래량
0.12M
기업 기본 정보
시가총액
25.4M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.38M
거래소
ASE
통화
USD
52주 범위
저가 $1.33현재가 $2.540고가 $6.2
관련 뉴스
GlobeNewswire
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating
더 보기
GlobeNewswire
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
Achieves significant expansion of NeurAxis' total addressable marketClearance now includes patients aged "8 years and older"Expanded age indication will utilize the upcoming January 1st, 2026, Category I CPT code to
더 보기
